Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
9,747,253
-
Shares change
-
-535,527
-
Total reported value, excl. options
-
$9,238,269
-
Value change
-
-$516,735
-
Number of buys
-
2
-
Number of sells
-
7
-
Price
-
$0.9478
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q4 2024
20 filings reported holding PMN - ProMIS Neurosciences Inc. - Common Shares, no par value per share as of 31 Dec 2024.
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,747,253 shares of stock of the company.
Largest 10 holders included GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Altium Capital Management LLC, Allostery Investments LP, HEIGHTS CAPITAL MANAGEMENT, INC, BANK OF MONTREAL /CAN/, Hara Capital LLC, and IEQ CAPITAL, LLC.
This table shows the top 18 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.